Grandmother Died After Increasing Mounjaro Dose, Inquest Examines Weight-Loss Drug Link

A 73-year-old grandmother died after developing acute abdominal pain shortly after increasing her dose of Mounjaro, a weight-loss medication, an inquest has revealed. The case has raised concerns about both the medication's safety profile and whether hospital staff adequately investigated her symptoms before attributing them solely to the drug's known gastrointestinal effects.

The Timeline of Events

Caroline Savage, from Wortwell near Harleston in Norfolk, had been prescribed Mounjaro privately for approximately four months to manage her weight and address symptoms associated with lipoedema and lymphoedema. When she attended a private London clinic in July, she weighed 128 kilograms with a body mass index of 46. Her prescribing doctor, Dr Harvinder Chahal, discussed potential side effects including abdominal pain and constipation, and advised her to maintain adequate hydration while avoiding spicy food and carbonated beverages.

By October, her weight had decreased to 114 kilograms and she reported feeling well with no significant adverse effects. Her doctor advised her to complete two remaining doses at 7.5 milligrams before progressing to the 10 milligram strength. However, on the morning of October 18, Mrs Savage developed sudden and severe abdominal pain. An ambulance was called approximately 1:30 pm after her husband discovered her doubled over. She arrived at Norfolk and Norwich Hospital's rapid assessment area around 2:45 pm but remained in the ambulance due to overcrowding in the emergency department.

Hospital Response and Family Concerns

The inquest heard a senior clinical fellow in emergency medicine assessed Mrs Savage, though the hearing did not disclose complete details of the initial assessment. What has emerged, however, is that her family expressed significant concerns about the hospital's approach to her care. Her husband, Jeremy Savage, a long-serving South Norfolk district councillor, and other family members questioned whether medical staff were too readily attributing her symptoms to the medication rather than conducting thorough investigations into alternative causes for her acute condition.

This tension between rapid attribution to a known medication side effect and comprehensive diagnostic investigation represents a critical issue raised during the inquest proceedings. The hearing examined the extent to which Mounjaro's documented gastrointestinal side effects may have influenced clinical decision-making, potentially diverting attention from other serious underlying conditions that could have required immediate intervention.